ArticleHaematologica2014

Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach.

Giovanni Palladini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.